← All trials
NCT03368495
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 23, 2015
- Primary completion
- Apr 30, 2018
- Completion date
- Jun 30, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 882
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Pan American Health OrganizationLead sponsor
- Government of ArgentinaCollaborator
- Centers for Disease Control and Prevention (CDC)Collaborator
- Government of ArgentinaOverall official - principal investigator
- Pan American Health OrganizationSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.